Mostrando 5 resultados de: 5
Filtros aplicados
Publisher
Current Drug Targets(1)
European Journal of Clinical Pharmacology(1)
Journal of Psychopharmacology(1)
Pharmacogenomics Journal(1)
Pharmacopsychiatry(1)
Área temáticas
Farmacología y terapéutica(5)
Enfermedades(3)
Fisiología humana(2)
Bioquímica(1)
Salud y seguridad personal(1)
Origen
scopus(5)
Effect of CYP2D6 and CYP2C9 genotypes on fluoxetine and norfluoxetine plasma concentrations during steady-state conditions
ArticleAbstract: Objectives: CYP2D6 drug-metabolising enzyme has been shown to be involved in fluoxetine metabolism iPalabras claves:CYP2C9, CYP2D6, Selective serotonin reuptake inhibitorsAutores:Adrián LLerena, Berecz R., Dorado P., González A.P., Penãs-Lledó E.M.Fuentes:scopusLower frequency of CYP2C9*2 in Mexican-Americans compared to Spaniards
ArticleAbstract: Interethnic differences in cytochrome P450 polymorphism might be responsible, at least in part, forPalabras claves:CYP2C9, Hispanics, Mexican-Americans, pharmacogenetics, SpaniardsAutores:Adrián LLerena, Dorado P., Jepson R., Licinio J., O'Kirwan F., Wong M.L.Fuentes:scopusQTc interval, CYP2D6 and CYP2C9 genotypes and risperidone plasma concentrations
ArticleAbstract: The role of certain drug metabolizing enzymes in cardiotoxicity, such as CYP2D6 for thioridazine, haPalabras claves:9-hydroxy-risperidone, CYP2C9, CYP2D6, QTc, RisperidoneAutores:Adrián LLerena, Berecz R., De La Rubis A., Dorado P.Fuentes:scopusRelationship between haloperidol plasma concentration, debrisoquine metabolic ratio, CYP2D6 and CYP2C9 genotypes in psychiatric patients
ArticleAbstract: Background: Around seven percent of Caucasians are poor metabolizers of cytochrome P450, CYP2D6 duePalabras claves:Autores:Adrián LLerena, Berecz R., De la Rubia A., Dorado P.Fuentes:scopusThe role of cytochrome P450 enzymes in the metabolism of risperidone and its clinical relevance for drug interactions
ReviewAbstract: In the recent years it has been increasingly recognized that pharmacogenetical factors play an imporPalabras claves:CYP2D6, CYP3A4, metabolism, pharmacogenetics, RisperidoneAutores:Adrián LLerena, Berecz R., Cáceres M.C., De la Rubia A., Degrell I., Dorado P.Fuentes:scopus